FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048322017> ?p ?o ?g. }

• W2048322017 endingPage "93" @default.
• W2048322017 startingPage "93" @default.
• W2048322017 abstract "A 90-day study of sub-chronic oral toxicity of 20 nm positively charged zinc oxide nanoparticles in Sprague Dawley rats Hark-Soo Park,1 Seon-Ju Kim,1 Taek-Jin Lee,1 Geon-Yong Kim,1 EunHo Meang,1 Jeong-Sup Hong,1 Su-Hyon Kim,1 Sang-Bum Koh,1 Seung-Guk Hong,1 Yle-Shik Sun,1 Jin Seok Kang,2 Yu-Ri Kim,3 Meyoung-Kon Kim,3 Jayoung Jeong,4 Jong-Kwon Lee,4 Woo-Chan Son,5 Jae-Hak Park61General Toxicology Team, Korea Testing and Research Institute, Seoul, 2Department of Biomedical Laboratory Science, Namseoul University, Cheonan, 3Department of Biochemistry and Molecular Biology, Korea University Medical School and College, Seoul, 4National Institute of Food and Drug Safety Evaluation, Seoul, 5Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, 6Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, KoreaPurpose: The study reported here was conducted to determine the systemic oral toxicity and to find the no-observed-adverse-effect level of 20 nm positively charged zinc oxide (ZnOSM,20(+)) nanoparticles in Sprague Dawley rats for 90 days.Methods: For the 90-day toxicity study, the high dose was set as 500 mg per kg of body weight (mg/kg) and the middle and low dose were set to 250 mg/kg and 125 mg/kg, respectively. The rats were held for a 14-day recovery period after the last administration, to observe for the persistence or reduction of any toxic effects. A distributional study was also carried out for the systemic distribution of ZnOSM,20(+) NPs.Results: No rats died during the test period. There were no significant clinical changes due to the test article during the experimental period in functional assessment, body weight, food and water consumption, ophthalmological testing, urine analysis, necropsy findings, or organ weights, but salivation was observed immediately after administration in both sexes. The total red blood cell count was increased, and hematocrit, albumin, mean cell volume, mean cell hemoglobin, and mean cell hemoglobin concentration were decreased significantly compared with control in both 500 mg/kg groups. Total protein and albumin levels were decreased significantly in both sexes in the 250 and 500 mg/kg groups. Histopathological studies revealed acinar cell apoptosis in the pancreas, inflammation and edema in stomach mucosa, and retinal atrophy of the eye in the 500 mg/kg group.Conclusion: There were significant parameter changes in terms of anemia in the hematological and blood chemical analyses in the 250 and 500 mg/kg groups. The significant toxic change was observed to be below 125 mg/kg, so the no-observed-adverse-effect level was not determined, but the lowest-observed-adverse-effect level was considered to be 125 mg/kg in both sexes and the target organs were found to be the pancreas, eye, and stomach.Keywords: positive charge, oral-toxicity study, no-observed-adverse-effect level, ZnO" @default.
• W2048322017 created "2016-06-24" @default.
• W2048322017 creator A5002479472 @default.
• W2048322017 creator A5015993732 @default.
• W2048322017 creator A5029300438 @default.
• W2048322017 creator A5032271371 @default.
• W2048322017 creator A5034506002 @default.
• W2048322017 creator A5036555187 @default.
• W2048322017 creator A5040903156 @default.
• W2048322017 creator A5058923531 @default.
• W2048322017 creator A5061619952 @default.
• W2048322017 creator A5063329712 @default.
• W2048322017 creator A5063511808 @default.
• W2048322017 creator A5068136709 @default.
• W2048322017 creator A5078098236 @default.
• W2048322017 creator A5081299374 @default.
• W2048322017 creator A5081867533 @default.
• W2048322017 creator A5090885700 @default.
• W2048322017 creator A5091567203 @default.
• W2048322017 date "2014-12-01" @default.
• W2048322017 modified "2023-09-27" @default.
• W2048322017 title "A 90-day study of sub-chronic oral toxicity of 20 nm positively charged zinc oxide nanoparticles in Sprague Dawley rats" @default.
• W2048322017 cites W1835795335 @default.
• W2048322017 cites W1967966369 @default.
• W2048322017 cites W2018139913 @default.
• W2048322017 cites W2023226705 @default.
• W2048322017 cites W2025342788 @default.
• W2048322017 cites W203604404 @default.
• W2048322017 cites W2038503712 @default.
• W2048322017 cites W2048322017 @default.
• W2048322017 cites W2054438230 @default.
• W2048322017 cites W2075537695 @default.
• W2048322017 cites W2087468617 @default.
• W2048322017 cites W2089819235 @default.
• W2048322017 cites W2091320610 @default.
• W2048322017 cites W2097258495 @default.
• W2048322017 cites W2104808062 @default.
• W2048322017 cites W2106412044 @default.
• W2048322017 cites W2107283881 @default.
• W2048322017 cites W2107683780 @default.
• W2048322017 cites W2123208730 @default.
• W2048322017 cites W2127690133 @default.
• W2048322017 cites W2163339963 @default.
• W2048322017 cites W3140084713 @default.
• W2048322017 cites W4255003587 @default.
• W2048322017 doi "https://doi.org/10.2147/ijn.s57927" @default.
• W2048322017 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4279770" @default.
• W2048322017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25565829" @default.
• W2048322017 hasPublicationYear "2014" @default.
• W2048322017 type Work @default.
• W2048322017 sameAs 2048322017 @default.
• W2048322017 citedByCount "17" @default.
• W2048322017 countsByYear W20483220172014 @default.
• W2048322017 countsByYear W20483220172015 @default.
• W2048322017 countsByYear W20483220172016 @default.
• W2048322017 countsByYear W20483220172017 @default.
• W2048322017 countsByYear W20483220172018 @default.
• W2048322017 countsByYear W20483220172019 @default.
• W2048322017 countsByYear W20483220172020 @default.
• W2048322017 countsByYear W20483220172021 @default.
• W2048322017 countsByYear W20483220172022 @default.
• W2048322017 crossrefType "journal-article" @default.
• W2048322017 hasAuthorship W2048322017A5002479472 @default.
• W2048322017 hasAuthorship W2048322017A5015993732 @default.
• W2048322017 hasAuthorship W2048322017A5029300438 @default.
• W2048322017 hasAuthorship W2048322017A5032271371 @default.
• W2048322017 hasAuthorship W2048322017A5034506002 @default.
• W2048322017 hasAuthorship W2048322017A5036555187 @default.
• W2048322017 hasAuthorship W2048322017A5040903156 @default.
• W2048322017 hasAuthorship W2048322017A5058923531 @default.
• W2048322017 hasAuthorship W2048322017A5061619952 @default.
• W2048322017 hasAuthorship W2048322017A5063329712 @default.
• W2048322017 hasAuthorship W2048322017A5063511808 @default.
• W2048322017 hasAuthorship W2048322017A5068136709 @default.
• W2048322017 hasAuthorship W2048322017A5078098236 @default.
• W2048322017 hasAuthorship W2048322017A5081299374 @default.
• W2048322017 hasAuthorship W2048322017A5081867533 @default.
• W2048322017 hasAuthorship W2048322017A5090885700 @default.
• W2048322017 hasAuthorship W2048322017A5091567203 @default.
• W2048322017 hasBestOaLocation W20483220171 @default.
• W2048322017 hasConcept C126322002 @default.
• W2048322017 hasConcept C185592680 @default.
• W2048322017 hasConcept C197934379 @default.
• W2048322017 hasConcept C29730261 @default.
• W2048322017 hasConcept C33070731 @default.
• W2048322017 hasConcept C71924100 @default.
• W2048322017 hasConcept C86803240 @default.
• W2048322017 hasConcept C98274493 @default.
• W2048322017 hasConceptScore W2048322017C126322002 @default.
• W2048322017 hasConceptScore W2048322017C185592680 @default.
• W2048322017 hasConceptScore W2048322017C197934379 @default.
• W2048322017 hasConceptScore W2048322017C29730261 @default.
• W2048322017 hasConceptScore W2048322017C33070731 @default.
• W2048322017 hasConceptScore W2048322017C71924100 @default.
• W2048322017 hasConceptScore W2048322017C86803240 @default.
• W2048322017 hasConceptScore W2048322017C98274493 @default.
• W2048322017 hasLocation W20483220171 @default.
• W2048322017 hasLocation W20483220172 @default.

• next